Deferasirox Impurity 28 | CAS 1379261-17-2 - Request Quote
Deferasirox Impurity 28
| SZ CAT No: | SZ-D020045 |
| CAS No | 1379261-17-2 |
| Mol.F. | C9H9NO4 |
| Mol.Wt. | 195.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Deferasirox Impurity 28 is chemically Methyl 3-formamido-4-hydroxybenzoate. Deferasirox Impurity 28 is supplied with detailed characterization data compliant with regulatory guideline. Deferasirox Impurity 28 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Deferasirox.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1379261-17-2
Purchase 1379261-17-2
Order 1379261-17-2
Enquire 1379261-17-2
price of 1379261-17-2
1379261-17-2 Supplier
1379261-17-2 Manufacturer
1379261-17-2 Exporter
buy high quality Deferasirox Impurity 28
Purchase Deferasirox Impurity 28
Deferasirox Impurity 28 suppliers
Deferasirox Impurity 28 manufacturers
Deferasirox Impurity 28 price
Order Deferasirox Impurity 28
Enquire Deferasirox Impurity 28
Deferasirox Impurity 28 cost
Deferasirox Impurity 28 Supplier
Deferasirox Impurity 28 Distributor
Deferasirox Impurity 28 for Method Validation
Deferasirox Reference Standard
Deferasirox Impurity 28 for ANDA Filing
Deferasirox Impurity 28 for Forced Degradation Studies
Deferasirox Impurity 28 Identification Standards
Deferasirox Impurity 28 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.